🇦🇺 Australia Country × Condition
small lymphocytic lymphoma Clinical Trials in Australia
Active clinical trials for small lymphocytic lymphoma with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇺 Australia
Active Trials in Australia (2)
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Enrollment
614 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Enrollment
700 pts
Country
🇦🇺 Australia
Janssen Research & Development, LLC
View Trial → Frequently Asked Questions
How many small lymphocytic lymphoma clinical trials are active in Australia?
There are currently 2 active clinical trials for small lymphocytic lymphoma with sites in Australia, of which 2 are actively recruiting patients.
How can I join a small lymphocytic lymphoma clinical trial in Australia?
To join a small lymphocytic lymphoma clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are small lymphocytic lymphoma trials in Australia?
Active small lymphocytic lymphoma trials in Australia span Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.